Vanita Noronha

Vanita Noronha

Tata Memorial Centre - Mumbai / India
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4984648
टाटा मेमोरियल सेंटर
person_outline Vanita Noronha's MOST POPULAR ARTICLES
1-) Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer V Noronha, VM Patil, A Joshi, N Menon, A Chougule, A Mahajan, A Janu, ... Journal of Clinical Oncology 38 (2), 124-136, 2020 2792020
2-) Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ... Journal of Clinical Oncology 36 (11), 1064-1072, 2018 2592018
3-) Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trialV Murthy, P Maitre, S Kannan, G Panigrahi, R Krishnatry, G Bakshi, ...Journal of Clinical Oncology 39 (11), 1234-1242, 20212292021
4-) Primary non-Hodgkin\'s lymphoma of the liverV Noronha, NQ Shafi, JA Obando, S KummarCritical reviews in oncology/hematology 53 (3), 199-207, 20052332005
5-) Crizotinib: A comprehensive reviewA Sahu, K Prabhash, V Noronha, A Joshi, S DesaiSouth Asian journal of cancer 2 (2), 91, 20132072013